SE8304315L - Mjoldrygealkaloider, deras framstellning och anvendning - Google Patents

Mjoldrygealkaloider, deras framstellning och anvendning

Info

Publication number
SE8304315L
SE8304315L SE8304315A SE8304315A SE8304315L SE 8304315 L SE8304315 L SE 8304315L SE 8304315 A SE8304315 A SE 8304315A SE 8304315 A SE8304315 A SE 8304315A SE 8304315 L SE8304315 L SE 8304315L
Authority
SE
Sweden
Prior art keywords
alkyl
alkaloids
molding
preparation
agents
Prior art date
Application number
SE8304315A
Other languages
English (en)
Swedish (sv)
Other versions
SE8304315D0 (sv
Inventor
P Gull
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8304315D0 publication Critical patent/SE8304315D0/xx
Publication of SE8304315L publication Critical patent/SE8304315L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SE8304315A 1982-08-09 1983-08-08 Mjoldrygealkaloider, deras framstellning och anvendning SE8304315L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4772/82A CH649998A5 (de) 1982-08-09 1982-08-09 Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff.

Publications (2)

Publication Number Publication Date
SE8304315D0 SE8304315D0 (sv) 1983-08-08
SE8304315L true SE8304315L (sv) 1984-02-10

Family

ID=4282273

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8304315A SE8304315L (sv) 1982-08-09 1983-08-08 Mjoldrygealkaloider, deras framstellning och anvendning

Country Status (23)

Country Link
JP (1) JPS5948480A (OSRAM)
AT (1) AT383125B (OSRAM)
AU (1) AU563736B2 (OSRAM)
BE (1) BE897473A (OSRAM)
CA (1) CA1215972A (OSRAM)
CH (1) CH649998A5 (OSRAM)
DE (1) DE3327705A1 (OSRAM)
DK (1) DK361983A (OSRAM)
ES (1) ES524815A0 (OSRAM)
FI (1) FI73679C (OSRAM)
FR (1) FR2531433B1 (OSRAM)
GB (1) GB2125041B (OSRAM)
GR (1) GR78923B (OSRAM)
HU (1) HU187600B (OSRAM)
IL (1) IL69450A (OSRAM)
IT (1) IT1168961B (OSRAM)
MY (1) MY8700166A (OSRAM)
NL (1) NL8302776A (OSRAM)
NZ (1) NZ205181A (OSRAM)
PH (1) PH20385A (OSRAM)
PT (1) PT77168B (OSRAM)
SE (1) SE8304315L (OSRAM)
ZA (1) ZA835850B (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
HU193782B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof
FR2589734B1 (fr) * 1985-11-13 1988-09-02 Roussel Uclaf Utilisation de derives de l'ergoline a l'obtention d'un medicament a visee geriatrique
US4798834A (en) * 1987-08-31 1989-01-17 Eli Lilly And Company Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement
DE3913756A1 (de) * 1989-04-21 1990-10-25 Schering Ag 8(beta)-substituierte ergoline, verfahren zu ihrer herstellung und ihre verwendung
DE10212564B4 (de) * 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE41533B1 (en) * 1974-03-14 1980-01-30 Sandoz Ltd Thiomethyl ergolene derivatives
US3901894A (en) * 1974-06-06 1975-08-26 Lilly Co Eli 8-thiomethylergolines
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity

Also Published As

Publication number Publication date
BE897473A (fr) 1984-02-06
NZ205181A (en) 1986-07-11
PH20385A (en) 1986-12-08
ATA286383A (de) 1986-10-15
CH649998A5 (de) 1985-06-28
DE3327705A1 (de) 1984-02-09
IL69450A (en) 1986-10-31
ES8502992A1 (es) 1985-02-01
NL8302776A (nl) 1984-03-01
SE8304315D0 (sv) 1983-08-08
DK361983D0 (da) 1983-08-08
HU187600B (en) 1986-01-28
GB8321222D0 (en) 1983-09-07
FI832789A0 (fi) 1983-08-02
JPS5948480A (ja) 1984-03-19
FR2531433A1 (fr) 1984-02-10
FR2531433B1 (fr) 1985-10-18
ZA835850B (en) 1985-03-27
AU563736B2 (en) 1987-07-23
FI832789L (fi) 1984-02-10
AU1767283A (en) 1984-02-16
FI73679B (fi) 1987-07-31
GB2125041B (en) 1986-04-23
CA1215972A (en) 1986-12-30
IT1168961B (it) 1987-05-20
FI73679C (fi) 1987-11-09
PT77168A (en) 1983-09-01
DK361983A (da) 1984-02-10
MY8700166A (en) 1987-12-31
PT77168B (en) 1986-03-27
AT383125B (de) 1987-05-25
ES524815A0 (es) 1985-02-01
GR78923B (OSRAM) 1984-10-02
GB2125041A (en) 1984-02-29
IL69450A0 (en) 1983-11-30
IT8322490A0 (it) 1983-08-09

Similar Documents

Publication Publication Date Title
IL70528A0 (en) Pharmaceutical compositions comprising derivatives of naphthaleneor azanaphthalenecarboxamide,novel derivatives of such compounds and processes for their preparation
NO832794L (no) Mellomprodukter for fremstilling av omeprazoler
FI852974A0 (fi) Nya n-hydroxylgruppen skyddande grupper och framstaellningsfoerfarande foer 3-acylamino-1-hydroxi-2-azetidinoner.
DK633088D0 (da) Hidtil ukendte forbindelser
NO833346L (no) Fremgangsmaate ved fremstilling av nye diazabicyclo-(3,3,1)-nonaner
EP0224163A3 (en) Propyl amines, process for their preparation and their use as fungicides
SE8304315L (sv) Mjoldrygealkaloider, deras framstellning och anvendning
DE3362504D1 (en) 1-carboxyalkanoylindoline-2-carboxylic-acid esters, their preparation, pharmaceutical compositions containing them, and their therapeutic use
SE8204418D0 (sv) N-imidazolyl-derivat av 1,2,3,4-tetrahydronaftalen, indan och 2-substituerad-1-kroman, och forfarande for deras framstellning
FI892681A0 (fi) Nya jodade icke-joniska trijodbenzenfoereningar och dessa innehaollande kontrastmedel.
EP0108547A3 (en) 1-bromoethyl ethyl carbonate and its use in the preparation of 1'-ethoxy-carbonyloxyethyl esters of penicillins and novel intermediates, methods for its preparation and 1-bromoethylchloroformate and 1-bromoethylbromoformate obtained as intermediates
FI890187A0 (fi) Foerfarande foer framstaellning av hydroxialkylerande foereningar, saolunda erhaollna nya foereningar och deras anvaendning.
SE8702936L (sv) Hydroximsyror av 7-oxabicykloheptansubstituerade etrar och tioetrar
NO834566L (no) Fremgangsmaate ved fremstilling av imidazolderivater
DE3168178D1 (en) 2-(n-aryl-n-1,2,3-thiadiazolyl-carbonyl)-aminobutyrolactones, their preparation, fungicides containing them and their use as fungicides
SE8701524L (sv) Nya sulfonamider och deras framstaellningsfoerfarande
ES515047A0 (es) Procedimiento para la obtencion de derivados de cefalosporina.
IL63964A0 (en) Cephalosporin derivatives,their preparation and pharmaceutical compositions containing them
DK87483D0 (da) Fremgangsmade til fremstilling af vinyloge carboxamider
SE8302972D0 (sv) Nya karbamidkompositioner
ATE36536T1 (de) Phosphoroimidate.
IE821616L (en) Heterocyclic phenylethyl anti-depressants
FI833971A0 (fi) Nya semikarbazider, deras framstaellning och anvaendning

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8304315-8